All 0 3 0 3 O
patients 4 12 4 12 O
with 13 17 13 17 O
histologic 18 28 18 28 O
proof 29 34 29 34 O
of 35 37 35 37 O
malignant 38 47 38 47 B-cancer
melanoma 48 56 48 56 I-cancer

Creatinine 0 10 57 67 B-clinical_variable
clearance 11 20 68 77 I-clinical_variable
> 21 22 78 79 O
30 23 25 80 82 B-lower_bound
ml 26 28 83 85 I-lower_bound
/ 28 29 85 86 I-lower_bound
min 29 32 86 89 I-lower_bound

Female 0 6 90 96 B-gender
patients 7 15 97 105 I-gender
of 16 18 106 108 O
childbearing 19 31 109 121 O
age 32 35 122 125 B-age
are 36 39 126 129 O
excluded 40 48 130 138 O
if 49 51 139 141 O
they 52 56 142 146 O
are 57 60 147 150 B-pregnancy
pregnant 61 69 151 159 I-pregnancy
as 70 72 160 162 O
determined 73 83 163 173 O
with 84 88 174 178 O
a 89 90 179 180 O
serum 91 96 181 186 B-clinical_variable
beta 97 101 187 191 I-clinical_variable
HCG 102 105 192 195 I-clinical_variable
no 106 108 196 198 O
greater 109 116 199 206 O
than 117 121 207 211 O
14 122 124 212 214 B-lower_bound
days 125 129 215 219 I-lower_bound
prior 130 135 220 225 I-lower_bound
to 136 138 226 228 O
study 139 144 229 234 O
registration 145 157 235 247 O
, 157 158 247 248 O
or 159 161 249 251 O
breast 162 168 252 258 O
- 168 169 258 259 O
feeding 169 176 259 266 O

Greater 0 7 267 274 O
than 8 12 275 279 O
3 13 14 280 281 B-lower_bound
presumed 15 23 282 290 O
melanoma 24 32 291 299 B-cancer
brain 33 38 300 305 I-cancer
metastases 39 49 306 316 I-cancer
on 50 52 317 319 O
contrast 53 61 320 328 B-treatment
- 61 62 328 329 I-treatment
enhanced 62 70 329 337 I-treatment
brain 71 76 338 343 I-treatment
MRI 77 80 344 347 I-treatment
scan 81 85 348 352 I-treatment
obtained 86 94 353 361 O
no 95 97 362 364 O
greater 98 105 365 372 O
than 106 110 373 377 O
4 111 112 378 379 B-upper_bound
weeks 113 118 380 385 I-upper_bound
prior 119 124 386 391 I-upper_bound
to 125 127 392 394 O
study 128 133 395 400 O
registration 134 146 401 413 O

Histologic 0 10 414 424 O
confirmation 11 23 425 437 O
may 24 27 438 441 O
be 28 30 442 444 O
from 31 35 445 449 O
the 36 39 450 453 O
primary 40 47 454 461 O
tumor 48 53 462 467 B-cancer
site 54 58 468 472 O
, 58 59 472 473 O
or 60 62 474 476 O
from 63 67 477 481 O
another 68 75 482 489 O
metastatic 76 86 490 500 O
site 87 91 501 505 O
( 92 93 506 507 O
systemic 93 101 507 515 B-cancer
lymph 102 107 516 521 I-cancer
node 108 112 522 526 I-cancer
, 112 113 526 527 O
etc 114 117 528 531 O
) 117 118 531 532 O

Patients 0 8 533 541 O
are 9 12 542 545 O
excluded 13 21 546 554 O
if 22 24 555 557 O
there 25 30 558 563 O
is 31 33 564 566 O
any 34 37 567 570 O
history 38 45 571 578 O
of 46 48 579 581 O
gadolinium 49 59 582 592 B-allergy_name
allergy 60 67 593 600 O

Patients 0 8 601 609 O
are 9 12 610 613 O
excluded 13 21 614 622 O
if 22 24 623 625 O
there 25 30 626 631 O
is 31 33 632 634 O
radiographic 34 46 635 647 O
or 47 49 648 650 O
cerebrospinal 50 63 651 664 O
fluid 64 69 665 670 O
( 70 71 671 672 O
CSF 71 74 672 675 O
) 74 75 675 676 O
evidence 76 84 677 685 O
of 85 87 686 688 O
leptomeningeal 88 102 689 703 B-cancer
disease 103 110 704 711 I-cancer

Patients 0 8 712 720 O
are 9 12 721 724 O
excluded 13 21 725 733 O
if 22 24 734 736 O
they 25 29 737 741 O
are 30 33 742 745 O
unable 34 40 746 752 O
to 41 43 753 755 O
obtain 44 50 756 762 O
a 51 52 763 764 O
magnetic 53 61 765 773 B-treatment
resonance 62 71 774 783 I-treatment
imaging 72 79 784 791 I-treatment
( 80 81 792 793 I-treatment
MRI 81 84 793 796 I-treatment
) 84 85 796 797 I-treatment
scan 86 90 798 802 I-treatment
for 91 94 803 806 O
any 95 98 807 810 O
other 99 104 811 816 O
reason 105 111 817 823 O

Patients 0 8 824 832 O
are 9 12 833 836 O
excluded 13 21 837 845 O
if 22 24 846 848 O
they 25 29 849 853 O
have 30 34 854 858 O
a 35 36 859 860 O
history 37 44 861 868 O
of 45 47 869 871 O
metastatic 48 58 872 882 B-cancer
cancer 59 65 883 889 B-cancer
in 66 68 890 892 O
addition 69 77 893 901 O
to 78 80 902 904 O
melanoma 81 89 905 913 O
or 90 92 914 916 O
a 93 94 917 918 O
history 95 102 919 926 O
of 103 105 927 929 O
uncontrolled 106 118 930 942 O
non 119 122 943 946 O
- 122 123 946 947 O
metastatic 123 133 947 957 O
cancer 134 140 958 964 O

Patients 0 8 965 973 O
are 9 12 974 977 O
excluded 13 21 978 986 O
if 22 24 987 989 O
they 25 29 990 994 O
have 30 34 995 999 O
been 35 39 1000 1004 O
treated 40 47 1005 1012 O
with 48 52 1013 1017 O
whole 53 58 1018 1023 B-treatment
brain 59 64 1024 1029 I-treatment
radiotherapy 65 77 1030 1042 I-treatment
within 78 84 1043 1049 O
the 85 88 1050 1053 O
prior 89 94 1054 1059 B-upper_bound
3 95 96 1060 1061 I-upper_bound
months 97 103 1062 1068 I-upper_bound

Patients 0 8 1069 1077 O
can 9 12 1078 1081 O
be 13 15 1082 1084 O
undergoing 16 26 1085 1095 O
concurrent 27 37 1096 1106 B-treatment
systemic 38 46 1107 1115 I-treatment
therapy 47 54 1116 1123 I-treatment
, 54 55 1123 1124 O
such 56 60 1125 1129 O
as 61 63 1130 1132 O
temozolomide 64 76 1133 1145 B-treatment
, 76 77 1145 1146 O
at 78 80 1147 1149 O
the 81 84 1150 1153 O
discretion 85 95 1154 1164 O
of 96 98 1165 1167 O
their 99 104 1168 1173 O
treating 105 113 1174 1182 O
oncologist 114 124 1183 1193 O

Patients 0 8 1194 1202 O
must 9 13 1203 1207 O
be 14 16 1208 1210 O
eligible 17 25 1211 1219 O
to 26 28 1220 1222 O
have 29 33 1223 1227 O
all 34 37 1228 1231 O
lesions 38 45 1232 1239 B-chronic_disease
treated 46 53 1240 1247 O
as 54 56 1248 1250 O
determined 57 67 1251 1261 O
by 68 70 1262 1264 O
the 71 74 1265 1268 O
study 75 80 1269 1274 O
radiation 81 90 1275 1284 O
oncologist 91 101 1285 1295 O

Patients 0 8 1296 1304 O
must 9 13 1305 1309 O
have 14 18 1310 1314 O
Karnofsky 19 28 1315 1324 B-clinical_variable
performance 29 40 1325 1336 I-clinical_variable
status 41 47 1337 1343 I-clinical_variable
( 48 49 1344 1345 I-clinical_variable
KPS 49 52 1345 1348 I-clinical_variable
) 52 53 1348 1349 I-clinical_variable
> 54 55 1350 1351 O
= 55 56 1351 1352 O
70 57 59 1353 1355 B-lower_bound

Patients 0 8 1356 1364 O
should 9 15 1365 1371 O
have 16 20 1372 1376 O
normal 21 27 1377 1383 O
coagulation 28 39 1384 1395 O
( 40 41 1396 1397 O
international 41 54 1397 1410 B-clinical_variable
normalized 55 65 1411 1421 I-clinical_variable
ratio 66 71 1422 1427 I-clinical_variable
[ 72 73 1428 1429 I-clinical_variable
INR 73 76 1429 1432 I-clinical_variable
] 76 77 1432 1433 I-clinical_variable
< 78 79 1434 1435 O
1.3 80 83 1436 1439 B-upper_bound
) 83 84 1439 1440 O
and 85 88 1441 1444 O
be 89 91 1445 1447 O
able 92 96 1448 1452 O
to 97 99 1453 1455 O
withhold 100 108 1456 1464 O
anticoagulation 109 124 1465 1480 B-treatment
/ 124 125 1480 1481 O
antiplatelet 125 137 1481 1493 B-treatment
medications 138 149 1494 1505 I-treatment
a 150 151 1506 1507 O
minimum 152 159 1508 1515 O
of 160 162 1516 1518 O
24 163 165 1519 1521 B-lower_bound
hours 166 171 1522 1527 I-lower_bound
prior 172 177 1528 1533 I-lower_bound
to 178 180 1534 1536 O
radiosurgery 181 193 1537 1549 B-treatment
treatment 194 203 1550 1559 I-treatment
( 204 205 1560 1561 O
or 205 207 1561 1563 O
until 208 213 1564 1569 O
INR 214 217 1570 1573 O
normalizes 218 228 1574 1584 O
) 228 229 1584 1585 O

Platelets 0 9 1586 1595 B-clinical_variable
> 10 11 1596 1597 O
50,000 12 18 1598 1604 B-lower_bound

on 0 2 1605 1607 O
the 3 6 1608 1611 O
day 7 10 1612 1615 O
of 11 13 1616 1618 O
treatment 14 23 1619 1628 B-treatment
and 24 27 1629 1632 O
24 28 30 1633 1635 B-upper_bound
hours 31 36 1636 1641 I-upper_bound
after 37 42 1642 1647 I-upper_bound
radiosurgery 43 55 1648 1660 B-treatment
treatment 56 65 1661 1670 I-treatment
has 66 69 1671 1674 O
concluded 70 79 1675 1684 O

